150 related articles for article (PubMed ID: 10152237)
1. Mechanical ventilation innovations: the manufacturer's perspective.
DeVries DF
Respir Care; 1995 Sep; 40(9):942-6. PubMed ID: 10152237
[TBL] [Abstract][Full Text] [Related]
2. Case studies on mechanical ventilator innovations: perspectives of two clinicians.
Hess D; Branson R
Respir Care; 1995 Sep; 40(9):957-67. PubMed ID: 10152240
[No Abstract] [Full Text] [Related]
3. Current limitations of mechanical ventilation: what improvements should the clinician expect?
Pierson DJ
Respir Care; 1995 Sep; 40(9):933-41. PubMed ID: 10152236
[No Abstract] [Full Text] [Related]
4. FDA: the regulatory process.
Slutsky AS
Respir Care; 1995 Sep; 40(9):952-6. PubMed ID: 10152239
[No Abstract] [Full Text] [Related]
5. Introducing new mechanical ventilation technology: the hospital perspective.
Kacmarek RM
Respir Care; 1995 Sep; 40(9):947-51. PubMed ID: 10152238
[TBL] [Abstract][Full Text] [Related]
6. Efficacy assessment criteria based on risk and cost.
MacIntyre NR
Respir Care; 1995 Sep; 40(9):968-70. PubMed ID: 10152241
[No Abstract] [Full Text] [Related]
7. Clinical outcome end points and assessment of mechanical ventilation innovations.
Dellinger RP
Respir Care; 1995 Sep; 40(9):975-9. PubMed ID: 10152243
[No Abstract] [Full Text] [Related]
8. The changing environment for technological innovation in health care.
Goodman CS; Gelijns AC
Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
[TBL] [Abstract][Full Text] [Related]
9. Using physiologic end points to assess innovations in mechanical ventilation.
Tobin MJ; Jubran A; Laghi F; Dhand R
Respir Care; 1995 Sep; 40(9):971-4. PubMed ID: 10152242
[TBL] [Abstract][Full Text] [Related]
10. Preparing for an FDA preapproval inspection.
Blackmer RA
Qual Assur; 1994 Dec; 3(4):389-403. PubMed ID: 7613749
[TBL] [Abstract][Full Text] [Related]
11. A new system for understanding modes of mechanical ventilation.
Chatburn RL; Primiano FP
Respir Care; 2001 Jun; 46(6):604-21. PubMed ID: 11353550
[TBL] [Abstract][Full Text] [Related]
12. Health-benefit claims for probiotic products.
Heimbach JT
Clin Infect Dis; 2008 Feb; 46 Suppl 2():S122-4; discussion S144-51. PubMed ID: 18181716
[TBL] [Abstract][Full Text] [Related]
13. FDA embraces risk-management approach.
Fox JL
Nat Biotechnol; 2003 Oct; 21(10):1120-1. PubMed ID: 14520383
[No Abstract] [Full Text] [Related]
14. Biomedical innovation: a risky business at risk.
Stack RS; Harrington RA
Sci Transl Med; 2011 Aug; 3(96):96cm23. PubMed ID: 21849662
[TBL] [Abstract][Full Text] [Related]
15. Resources for assessing innovations in mechanical ventilatory support: the missing link.
East TD
Respir Care; 1995 Sep; 40(9):987-93. PubMed ID: 10152245
[No Abstract] [Full Text] [Related]
16. Of specialty interest: the Food and Drug Administration: a partner in safe practice.
Baker K
ORL Head Neck Nurs; 2003; 21(2):25-7. PubMed ID: 12747041
[TBL] [Abstract][Full Text] [Related]
17. Can surgical innovation survive? Panel presentations.
McKneally MF; Gleeson S; Balch CM; Mussallem MA; Abel DB; Bernhard VM
Bull Am Coll Surg; 1996 Apr; 81(4):8-21, 43. PubMed ID: 10156765
[No Abstract] [Full Text] [Related]
18. Vendor discusses high-frequency ventilators.
Bunnell JB
Hosp Mater Manage; 1991 Dec; 16(12):13. PubMed ID: 10124776
[No Abstract] [Full Text] [Related]
19. Evidence, appropriateness, and technology assessment in cardiology: a case study of computed tomography.
Redberg RF
Health Aff (Millwood); 2007; 26(1):86-95. PubMed ID: 17211017
[TBL] [Abstract][Full Text] [Related]
20. Health technology assessment from a Canadian device industry perspective.
Ferrusi IL; Ames D; Lim ME; Goeree R
J Am Coll Radiol; 2009 May; 6(5):353-9. PubMed ID: 19394576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
